Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Bavarian Nordic AS's accounts receivables for the quarter that ended in Mar. 2026 was kr882 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
Bavarian Nordic AS's Days Sales Outstanding for the quarter that ended in Mar. 2026 was 76.04.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Bavarian Nordic AS's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was kr37.22.
Bavarian Nordic AS Accounts Receivable Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Bavarian Nordic AS's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Bavarian Nordic AS's accounts receivable are only considered to be worth 75% of book value:
Bavarian Nordic AS's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Bavarian Nordic AS Accounts Receivable Related Terms
Bavarian Nordic AS Accounts Receivable Historical Data
* Premium members only.
The historical data trend for Bavarian Nordic AS's Accounts Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Accounts Receivable of kr882 Mil mean?
Bavarian Nordic AS (CHIX:BAVAC) has a Accounts Receivable of kr882 Mil as of Mar. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Bavarian Nordic AS and its competitors.
Is Bavarian Nordic AS's Accounts Receivable too high?
Bavarian Nordic AS's current Accounts Receivable is kr882 Mil. Overall, Bavarian Nordic AS has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Bavarian Nordic AS's Accounts Receivable compare to VRTX and REGN?
Bavarian Nordic AS's Accounts Receivable of kr882 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Biotechnology company?
A good Accounts Receivable depends on the Biotechnology industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Bavarian Nordic AS and its competitors. Bavarian Nordic AS's current Accounts Receivable is kr882 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bavarian Nordic AS stock overvalued right now?
Bavarian Nordic AS (CHIX:BAVAC) has a current Accounts Receivable of kr882 Mil. The stock's GF Value™ is kr160.71, compared to a current price of kr188.30 — trading 17.2% above its estimated fair value. The current Accounts Receivable is kr882 Mil. Bavarian Nordic AS's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Bavarian Nordic AS (CHIX:BAVAC), the current Accounts Receivable is kr882 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bavarian Nordic AS (CHIX:BAVAC) Overvalued in 2026?
Based on GuruFocus' analysis, Bavarian Nordic AS stock appears to be overvalued.
The current stock price of kr188.30 is trading 17.2% above its estimated GF Value™ of kr160.71.
Key valuation signals for CHIX:BAVAC:
Accounts Receivable: kr882 Mil
GF Value™: kr160.71 vs. price of kr188.30 (17.2% above fair value)
No single metric tells the full story. See the CHIX:BAVAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora, VIMKUNYA and Vivotif.
75GF Score
Get the complete analysis for CHIX:BAVAC
Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BAVAC has been successfully added to your 
